SEARCH · PubMed Health
Explore indexed PubMed citations for clinical trials, systematic reviews and public health research. Read source abstracts and follow each citation to its original PubMed record.
Quote a phrase for an exact phrase match. Source license links do not imply unrestricted reuse.
Hyperopia of 1.00, 1.50, and 2.00 D was induced in 42 subjects by means of concave lenses. A significant decrease in performance on a standard intelligence test occurred with the highest-power lenses. Symptoms induced indicate that the results are applicable to hyperopia. Prescriptions and vision screening criteria for hyperopia are indicated.
Myopia and hyperopia have been produced in chicks by applying specially designed convex and concave soft contact lenses to the eyes of newly hatched birds. After 2 weeks of wear, the eyes develop refractive states equivalent in sign and amount (+8 and -10 D) to the lens used. However, the lenses produce an artificial hyperopic shift during the first week of wear due to corneal flattening. We have developed a new approach involving the use of goggles with hard convex and concave contact lens inserts placed between the frontal and lateral visual fields. Myopia and hyperopia (+10 and -10 D) can be produced within days (4 days for hyperopia and 7 days for myopia) if the defocus is applied from the day of hatching. We can also produce significant amounts of astigmatism (1 to 5 D) axis at 90 degrees and 180 degrees by using cylindrical contact lens inserts. Although these last results are preliminary, they suggest that accommodation is not likely involved at this stage of refractive development because we do not believe that the accommodative mechanism can cope with cylindrical defocus. All spherical refractive errors produced using the goggle system appear to result from alterations in vitreous chamber depth.
PURPOSE: To evaluate the treatment of surgically induced astigmatism intraoperatively during conductive keratoplasty (CK) for correcting hyperopia. METHODS: Conductive keratoplasty uses radiofrequency energy applied to the peripheral corneal stroma to shrink the collagen and alter the central cornea to correct hyperopia. Nineteen consecutive patients (27 eyes) who underwent CK for hyperopia and were treated intraoperatively for induced astigmatism were examined. By using automated keratometric readings taken during the procedure, additional spots were applied at the minus cylinder or flat axis at the 7-mm zone until the intraoperative astigmatism was 2 diopters (D) or less. RESULTS: The intraoperative treatment reduced the astigmatism by an average of 2.30 +/- 1.32 D (P=0.00001). The mean induced astigmatism was 3.33 +/- 0.14 D for eyes that received eight spots, 4.12 +/- 1.13 D for eyes that received 16 spots, 4.43 +/- 0.82 D for eyes that received 24 spots, and 4.60 +/- 1.08 D for eyes that received 32 spots. Additional spots reduced astigmatism in most patients to less than 2 D. CONCLUSIONS: Intraoperative treatment of astigmatism through the addition of more spots at the minus cylinder or flat axis reduced the degree of induced astigmatism. Surgically induced astigmatism was observed more frequently in patients who received 32 treatment spots and 6-mm treatment zone application.
PURPOSE: To report the development of progressive hyperopia and astigmatism resulting from peripheral hypertrophic subepithelial degeneration which was treated with superficial keratectomy of the lesion. METHODS: Case report. RESULTS: A patient with peripheral hypertrophic subepithelial degeneration of both corneas was followed up for a 6-year period. During this time, the patient experienced a slowly progressive increase in hyperopia and astigmatism in both eyes. In the left eye, extension of the degeneration paracentrally resulted in significant hyperopia and astigmatism and a best spectacle-corrected visual acuity of 20/70. Superficial keratectomy was performed and resulted in a dramatic reversal of the hyperopic and astigmatic shift and a best spectacle-corrected visual acuity of 20/30. CONCLUSIONS: Peripheral hypertrophic subepithelial corneal degeneration can result in progressive flattening of the central corneal topography in the involved meridians. This flattening can induce a significant hyperopic and astigmatic shift in refraction. This refractive change can be reversed with superficial keratectomy to remove the degeneration.
BACKGROUND: Overcorrection following myopic photorefractive keratectomy, with a target of emmetropia, leaving a spherical equivalent of more than 1.0 D of hyperopia is of the order of 1%. This study analyses the efficacy, safety, and 1 year stability of outcome of laser thermokeratoplasty (LTK) carried out on eyes with persistent symptomatic hyperopia following photorefractive keratectomy (PRK) for myopia. METHOD: 11 consecutive eyes in 11 patients underwent LTK using the Technomed Holmium 25, contact holmium:YAG laser system. The mean spherical equivalent before LTK was +2.06 D (SD 1.02 D, range +1.00 D to +4.75 D) based on a non-cycloplegic refraction. Between four and 16 burns were used per eye, depending on the error to be corrected. RESULTS: The mean spherical equivalent was +0.511 D (SD 0.551) at 1 year. Ten of the 11 eyes were seeing 6/12 or greater, unaided (91%) and nine were within 1.0 D of the target sphere equivalent (82%). Recovery of unaided acuity occurred during the first week in four cases and the first month in the rest. One eye lost greater than one line of best corrected vision (9%), going from 6/5 to 6/7.5 and one gained a line (9%), 6/12 to 6/7.5. No complications occurred during the follow up period. CONCLUSIONS: In this study of a small number of eyes with hyperopia induced by PRK, LTK appears safe, predictable, and stable for low errors followed for 1 year.
PURPOSE: To assess the safety and efficacy of noncontact holmium:yttrium aluminium garnet laser thermal keratoplasty (Ho:YAG LTK) for correction of low to moderate hyperopia. METHODS: We performed noncontact Ho:YAG LTK on 1 eye each of 28 patients for correction of hyperopia up to +3.88 dpt. Treatments were conducted with 1 or 2 symmetrical octagonal rings of 8 spots/ring with centerline diameters of 6 mm (1 ring) or 6 and 7 mm (2 rings), 10 pulses of laser light at 5 Hz pulse repetition frequency, variable pulse energy in the range of 208-242 mJ and a nominal spot diameter between 615 and 623 microns. RESULTS: At 18 months after surgery, 20 of 22 (91%) treated patient eyes had improved uncorrected distance visual acuity. The mean change in subjective manifest refraction (spherical equivalent) was -0.52 +/- 0.35 dpt and -1.41 +/- 0.53 dpt for 1- and 2-ring treatment groups, respectively, with good stability in the refractive change after 6 months. The mean induced refractive astigmatism was small (0.30 +/- 0.37 dpt/0.25 +/- 0.29 dpt for 1-/2-ring treatments). None of the eyes lost 2 or more lines of spectacle-corrected distance visual acuity. There were no clinically significant changes in glare and contrast sensitivity. CONCLUSIONS: Noncontact LTK treatment of low hyperopia is safe and effective, and it is more stable and less prone to induce astigmatism than previously reported contact mode LTK treatments.
PURPOSE: To evaluate the safety and effectiveness of non-contact holmium:YAG laser thermal keratoplasty in correcting hyperopia induced by photorefractive keratectomy (PRK). METHODS: Non-contact holmium:YAG laser thermal keratoplasty was applied to 14 eyes with significant hyperopia induced by PRK. The mean spherical equivalent refraction before holmium:YAG laser thermal keratoplasty was +4.20 +/- 1.80 diopters (D) (range, +1.75 to +6.25 D). The results were evaluated 12 months after holmium:YAG laser thermal keratoplasty. RESULTS: No sight-threatening complications occurred. Recovery of spectacle-corrected visual acuity took from 2 to 6 weeks. The immediate significant myopic shift that developed in all eyes gradually receded over 6 to 8 weeks. All eyes were relatively stable after 9 months. At 12 months, there was no statistically significant difference (p < .005) between the mean preoperative spectacle-corrected visual acuity (0.71 +/- 0.12) and the mean postoperative uncorrected visual acuity (0.65 +/- 0.28). At 12 months there was a mean increase of 4.60 +/- 1.20 D in central keratometric power. Total regression did not occur in any eye. CONCLUSIONS: Non-contact holmium:YAG laser thermal keratoplasty offers a safe and effective alternative to correct PRK-induced hyperopia.
OBJECTIVE: To prospectively study excimer laser correction of hyperopia, with a 1-year followup. METHODS: Eleven consecutive hyperopic eyes (10 phakic and 1 aphakic) underwent correction of hyperopia using the Summit Technology SVS Apex Plus excimer laser. Data collection included cycloplegic refraction, spectacle-corrected visual acuity, contrast sensitivity, corneal haze, manual keratometry, and videokeratography. Prior to treatment the mean hyperopic spherical equivalent refraction (corneal plane) was +5.80 diopters (D) (SD2.10). The mean attempted correction was +3.09 D at the corneal plane. RESULTS: Refractive data for the group showed a mean overcorrection at 1 month of +3.18 D. This regressed slightly before stabilizing at 3 months, with a mean overcorrection of +1.88 D. Thereafter there was no statistically significant fluctuation in refraction (p = 0.67). The amount of overcorrection and regression was greater in eyes that received higher corrections. Changes in manual keratometry and videokeratography mirrored the attempted correction more closely than refraction, although stabilization did not occur until 6 months. CONCLUSIONS: Because the hyperopic correction achieved when measured by refraction was greater than expected, algorithms should be adjusted. The hyperopic erodible disc and Axicon lens system is capable of treating low to moderate amounts of hyperopia.
PURPOSE: To examine the efficacy, predictability, stability, and safety of posterior chamber phakic intraocular lens (IOL) implantation in eyes with high hyperopia. METHODS: We analyzed the results of 24 eyes that received a posterior chamber hydrogel-collagen plate phakic IOL (Staar Collamer Implantable Contact Lens, ICL) for the correction of hyperopia with the goal of emmetropia. Mean follow-up was 8.4 months (range, 1 to 18 mo). RESULTS: The mean preoperative spherical equivalent refraction was +6.51 +/- 2.08 D (range, +3.75 to +10.50 D). Mean postoperative spherical equivalent refraction at last examination was -0.39 +/- 1.29 D (range, +1.25 to -3.88 D), with 79% (19 eyes) within +/-1.00 D and 58% (14 eyes) within +/-0.50 D of emmetropia. Postoperative uncorrected visual acuity at last examination was 20/20 or better in 8% (two eyes) and 20/40 or better in 63% (15 eyes). A gain of two or more lines of spectacle-corrected visual acuity was seen in two eyes (8%) at last examination. One eye (4%) lost two or more lines of spectacle-corrected visual acuity due to progressive neovascular glaucoma initiated by early postoperative pupillary block. CONCLUSION: Posterior chamber phakic IOL implantation with the Staar Collamer plate lens is an effective method for correcting high hyperopia. Large, patent iridotomies are important in hyperopic eyes to lower the risk of postoperative pupillary block. Improved phakic IOL power calculation formulas will refine predictability of refractive outcome.
BACKGROUND: We describe a new technique of inferior off-center ablation with laser in situ keratomileusis (LASIK) to correct both hyperopia and presbyopia. METHODS: This prospective clinical study was based on the empirical results obtained with LASIK in 16 hyperopic eyes of 8 patients. All patients had a centered ablation in one eye and an inferior decentered ablation in the other eye. A Schwind excimer laser was used and a planned inferior off-center ablation of 1 mm was performed. Maximum follow-up was 22 months (8 eyes). RESULTS: Patients with hyperopia that underwent inferior decentered ablation were able to read for a prolonged period of time, compared with eyes that had conventional centered excimer laser ablation. Patients with steepened corneas in the inferior and eccentric zone ended up not only with better distance but also better near vision. No loss of spectacle-corrected visual acuity in any eye has been observed to date. CONCLUSION: Planned inferior off-center ablation to correct hyperopia and presbyopia achieved better distance and near visual acuity than centered ablation. As with centered ablation, no significant regression of effect occurred with off-center ablation; reading near vision was better and more stable with inferior off-center ablation.
PURPOSE: Current surgical options for the correction of moderate to severe hyperopia include hyperopic laser in situ keratomileusis (LASIK), phakic intraocular lens implantation and clear lens extraction with intraocular lens (IOL) implantation. We investigate the safety and efficacy of clear lens extraction with IOL implantation to correct hyperopia. METHODS: Phacoemulsification and IOL implantation was performed on 18 eyes of 10 patients. In 16 eyes, the Hoffer-Q formula was used for IOL power calculation and a single IOL was inserted; in the remaining 2 nanophthalmic eyes, the Holladay-II formula was used and two piggy-back IOLs were inserted. RESULTS: Mean preoperative spherical equivalent for distance was +6.17 D (range, +4.25 to +9.62 D). Patients were followed postoperatively for a mean of 10.5 months (range, 4 to 27 mo). Uncorrected visual acuity in all eyes was 20/50 or better with a median uncorrected visual acuity of 20/40 (range, 20/30 to 20/50). Two patients lost 2 lines of spectacle-corrected visual acuity; both of these patients achieved spectacle-corrected visual acuity of 20/30. CONCLUSIONS: Clear lens extraction with IOL implantation is a safe and effective procedure for the correction of moderate to severe hyperopia in the presbyopic age range.
PURPOSE: To evaluate prospectively the long-term safety, efficacy, and visual performance following photorefractive keratectomy (PRK) for hyperopia using an erodible mask and axicon lens system. METHODS: Eighteen eyes of 9 patients with a mean preoperative spherical equivalent refraction of +2.26 +/- 0.82 D (range, +1.13 to +4.00 D) underwent PRK with the Summit Apex Plus excimer laser following manual scraping of the epithelium. Eyes were prospectively evaluated 1, 3, 6, 9, 12, 18, and 24 months following the procedure. Primary outcome variables included cycloplegic refraction and uncorrected visual acuity (UCVA). Visual performance was determined by contrast sensitivity measurements under scotopic (21 lux) and photopic (324 lux) conditions and best spectacle-corrected visual acuity (BSCVA) under scotopic, photopic, and glare conditions. RESULTS: For 18 eyes, 98.2% of the mean preoperative spherical equivalent refraction was corrected to +0.04 +/- 0.87 D (range, -1.38 to +2.00 D) at 24 months after PRK. Twelve eyes (67%) were within +/-0.50 D of attempted correction and 15 eyes (83%) were within +/-1.00 D. Stability within +/-0.50 D was achieved after 6 months. Two eyes (11%) experienced almost complete regression of the refractive effect. There was no statistically significant decrease in contrast sensitivity under scotopic or photopic conditions. (P > .05). Best spectacle-corrected visual acuity showed progressive improvement in the early postoperative period. By 24 months, 0 eyes (0%) lost 2 or more lines of BSCVA under scotopic and photopic conditions and 1 eye (5.5%) lost 2 or more lines under glare conditions. Fourteen eyes (78%) had grade 1 to 3 anterior stromal haze at 24 months which was characteristically mid-peripheral and did not adversely affect visual performance. CONCLUSION: Photorefractive keratectomy with the the Summit Apex Plus excimer laser for low to moderate hyperopia resulted in an effective reduction of hyperopia without compromising long-term visual performance. Stability and recovery of distance uncorrected and best spectacle-corrected visual acuity took approximately 6 months.
PURPOSE: To assess the efficacy, predictability, stability, and safety of laser in situ keratomileusis (LASIK) in patients with hyperopia and to evaluate the visual and refractive results of the procedure. METHODS: LASIK was performed on 85 eyes of 53 patients for correction of hyperopia, with a preoperative mean manifest spherical equivalent refraction of +3.31 +/- 0.69 D (range, +1.25 to +5.00 D) and mean refractive astigmatism of +0.91 +/- 1.06 D (range, 0 to +3.00 D). The Carriazo-Barraquer (Moria) manual microkeratome was used to create the corneal flap, and laser ablation was performed using the Technolas Keracor 117C excimer laser with an ablation zone diameter of 6.0 mm and a transition zone diameter to 9.0 mm. Follow-up was 12 months for all patients. RESULTS: Refraction was stable by 3 months after surgery. At 1 year after LASIK, the mean manifest spherical equivalent refraction was +0.43 +/- 0.57 D (range, -1.25 to +2.00 D) and refractive astigmatism was reduced to a mean of 0.36 +/- 0.30 D (range, 0 to 1.00 D). Fifty-two eyes (61.2%) had a manifest spherical equivalent refraction within +/- 0.50 D of emmetropia, and 76 eyes (89.4%) were within +/- 1.00 D. Uncorrected visual acuity was 20/20 in 21 eyes (24.7%) and 20/40 or better in 79 eyes (92.9%). Spectacle-corrected visual acuity was reduced by two lines in one eye (1.2%) and improved by two lines in five eyes (5.9%). There were no significant complications. CONCLUSION: LASIK was an effective, safe, and predictable procedure for the correction of hyperopia up to +5.00 D and hyperopic astigmatism up to +3.00 D with the Technolas Keracor 117C excimer laser. The large size of the corneal flap obtained by the Carriazo-Barraquer (Moria) manual microkeratome facilitated laser ablation entirely in the exposed corneal stromal bed.
PURPOSE: To examine the effects of laser in situ keratomileusis (LASIK) for hyperopia on the tear film and ocular surface. METHODS: A retrospective 12-month analysis of 88 eyes (88 participants) who had LASIK for hyperopia was performed. Participants were evaluated before and after (2 weeks, 1, 3, 6, and 12 months) surgery for dry eye symptoms (McMonnies Dry Eye Survey primary symptoms), tear film stability (fluorescein break-up time), tear volume (phenol red thread test), ocular surface staining (fluorescein), and conjunctival goblet cell density. RESULTS: Chronic dry eye was experienced by 32% of participants; symptoms were significantly associated with female gender, preoperative dry eye symptoms, lower tear film stability after surgery, greater ocular surface staining after surgery, lower tear volume before and after surgery, and lower goblet cell densities after surgery. Regression rate 12 months after surgery was 32% and significantly associated with female gender, chronic dry eye symptoms, lower tear film stability after surgery, greater ocular surface staining before and after surgery, and lower tear volume before and after surgery. CONCLUSIONS: Dry eye, particularly in females, is problematic after LASIK for hyperopia and is associated with refractive regression. Current methods for managing the tear film and ocular surface may not control LASIK-induced dry eye, particularly in some females during the first 6 months after surgery.
PURPOSE: To evaluate the effects and safety of laser in situ keratomileusis (LASIK) and diode thermal keratoplasty (DTK) for correction of moderate to high hyperopia (+5.00 to +10.00 D). METHODS: This prospective study included 30 eyes of 15 patients who had LASIK-DTK bioptics. The median age of the patients was 50.5 years. LASIK was performed using a Nidek EC-5000 excimer laser system and DTK by a Prolaser DTK laser, 2 months after LASIK. Follow-up ranged from 9 to 12 months (mean, 10.5 mo). RESULTS: The mean preoperative spherical equivalent refraction was +8.25 +/- 0.25 D and mean postoperative was +1.00 +/- 0.50 D. The preoperative best spectacle-corrected visual acuity (BSCVA) was < or = 20/40 in 10 eyes and > or = 20/25 in 20 eyes. Postoperatively, BSCVA was < or = 20/40 in 8 eyes and > or = 20/25 in 22 eyes. No significant intra- or postoperative complications occurred. CONCLUSION: LASIK-DTK bioptics for correction of moderate to high hyperopia (+5.00 to +10.00 D) was safe and effective. In this method, two different ablative and non-ablative laser systems were used to compensate for regression, which is the most important concern in the correction of hyperopia.
PURPOSE: To assess the safety, efficacy, and stability of conductive keratoplasty in the treatment of low to moderate hyperopia and evaluate the impact of the procedure on the quality of vision. METHODS: Thirty-six eyes (25 patients; 13 female and 12 male) were treated for hyperopia up to +3.25 D with a Refractec ViewPoint CK system and followed for 1 year. Mean age was 50.2 +/- 8.7 years (range 31 to 71). RESULTS: Before surgery, mean spherical equivalent refraction was +1.90 +/- 0.60 D (range +1.00 to +3.25 D), decreasing at 1 year after conductive keratoplasty to -0.06 +/- 0.80 D, and was within +/- 0.50 D of emmetropia in 68% (24 eyes) and within +/- 2.00 D in all eyes. Twelve months after conductive keratoplasty, uncorrected visual acuity was 20/20 or better in 19 eyes (50%) and 20/40 or better in 32 eyes (89%). No eye lost > or = 2 Snellen lines or had induced cylinder > or = 2.00 D. The mean root mean square values for higher order optical aberrations were 0.060 +/- 0.039 before and 0.174 +/- 0.170 at 3 months after surgery. No statistically significant changes in contrast sensitivity were noted. CONCLUSIONS: Conductive keratoplasty for low to moderate hyperopia provided safe, effective, and stable results both in refraction and quality of vision.
PURPOSE: To assess the efficacy and safety of holmium laser thermal keratoplasty (Ho:LTK) for hyperopia in eyes overcorrected after laser in situ keratomileusis (LASIK) for myopia. METHODS: We performed a prospective evaluation of Ho:LTK in eyes with secondary hyperopia from +1.00 to +5.50 D after LASIK. Thirty-seven eyes of 23 patients received one concentric 8-spot application at the 6-mm-diameter zone. Mean patient age was 41.3 +/- 13.0 years (range 20 to 68 yr). Mean corneal thickness was 455.86 +/- 31.20 microm (range 373 to 506 microm). RESULTS: Mean spherical equivalent refraction changed from +2.30 +/- 1.08 D to +0.45 +/- 1.00 D at 12 months after Ho:LTK. Thirty-one eyes (84%) were within +/- 1.00 D of emmetropia and 25 eyes (68%) were within +/- 0.50 D at 1 year. Mean change in refraction was 1.84 +/- 0.92 D. No eye lost 2 lines of best spectacle-corrected visual acuity. CONCLUSIONS: Ho:LTK is a suitable alternative for correcting secondary hyperopia resulting from LASIK for myopia. Parameter adjustments may be necessary for improving the results.
PURPOSE: We evaluated short-term results and confocal microscopic corneal changes following intracorneal lens implantation. METHODS: In six eyes of three patients with hyperopia between +3.00 and +6.00 diopters (D), an intrastromal hydrogel lens (Permavision, Anamed, Anaheim, Calif) was implanted. Mean baseline hyperopia was +3.90 D. Manifest refraction, uncorrected visual acuity, and spectacle-corrected visual acuity were evaluated. We also performed confocal real-time microscopy with a water immersion objective. Corneal optical sections were recorded and reviewed frame by frame. Examinations were done at months 3, 6, and 12 after intracorneal lens implantation. RESULTS: After surgery, the spherical equivalent refraction was within +/- 0.50 D in 83% (five of six eyes) at 3 months and 100% (six eyes) at 6 and 12 months. Uncorrected visual acuity (UCVA) at 3 months was within 20/40 or better in 67% (four eyes) and in 100% (six eyes) at 6 and 12 months; no eyes had 20/20 or better UCVA at 3 and 6 months. One eye (17%) had 20/20 or better UCVA at 12 months. On confocal microscopy, one eye had an amorphous deposit adjacent to the lens and presumed fibroblastic activity in the same stromal area at 6 months, which was non-progressive up to 12 months. CONCLUSION: Intracorneal lenses may be a treatment option for correction of spherical hyperopia. Predictability must be improved but results in these six eyes were stable up to 1 year. Confocal miscroscopy confirmed biocompatibility and showed no abnormal changes, except two spots of hypercellularity in one eye.